130 related articles for article (PubMed ID: 2622863)
21. In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen.
Rautio J; Taipale H; Gynther J; Vepsalainen J; Nevalainen T; Jarvinen T
J Pharm Sci; 1998 Dec; 87(12):1622-8. PubMed ID: 10189277
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
23. Cleavage of tertiary amidomethyl ester prodrugs of carboxylic acids by rat liver homogenates.
Iley J; Mendes E; Moreira R; Souza S
Eur J Pharm Sci; 1999 Dec; 9(2):201-5. PubMed ID: 10620732
[TBL] [Abstract][Full Text] [Related]
24. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
[TBL] [Abstract][Full Text] [Related]
25. Multiple oral administration of a ketoprofen-dextran ester prodrug in pigs: assessment of gastrointestinal bioavailability by deconvolution.
Larsen F; Jensen BH; Olesen HP; Larsen C
Pharm Res; 1992 Jul; 9(7):915-9. PubMed ID: 1279651
[TBL] [Abstract][Full Text] [Related]
26. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
27. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
Uekama K; Minami K; Hirayama F
J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
[TBL] [Abstract][Full Text] [Related]
28. [Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates].
Zhou SY; Mei QB; Liu L; Zhang BL; Li C; Zhou J
Yao Xue Xue Bao; 2003 May; 38(5):388-91. PubMed ID: 12958847
[TBL] [Abstract][Full Text] [Related]
29. Colon-specific prodrugs of 5-radioiodo-2'-deoxyuridine.
Baranowska-Kortylewicz J; Kortylewicz ZP; Hoffman D; Winoto A; Lai J; Dalrymple GV
Acta Oncol; 1996; 35(7):959-64. PubMed ID: 9004778
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic results on naproxen prodrugs based on poly(ethyleneglycol)s.
Ranucci E; Sartore L; Peroni I; Latini R; Bernasconi R; Ferruti P
J Biomater Sci Polym Ed; 1994; 6(2):141-7. PubMed ID: 7947480
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
Sheha M
Arch Pharm Res; 2012 Mar; 35(3):523-30. PubMed ID: 22477200
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen and naproxen.
Samara E; Avnir D; Ladkani D; Bialer M
Biopharm Drug Dispos; 1995 Apr; 16(3):201-10. PubMed ID: 7787132
[TBL] [Abstract][Full Text] [Related]
34. Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats.
Chopade SS; Dhaneshwar SS
World J Gastroenterol; 2018 Mar; 24(10):1093-1106. PubMed ID: 29563754
[TBL] [Abstract][Full Text] [Related]
35. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
Sarkate A; Dhaneshwar SS
World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat.
McLeod AD; Tolentino L; Tozer TN
Biopharm Drug Dispos; 1994 Mar; 15(2):151-61. PubMed ID: 7516722
[TBL] [Abstract][Full Text] [Related]
37. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.
Zou MJ; Cheng G; Okamoto H; Hao XH; An F; Cui FD; Danjo K
World J Gastroenterol; 2005 Dec; 11(47):7457-60. PubMed ID: 16437716
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen.
Tammara VK; Narurkar MM; Crider AM; Khan MA
Pharm Res; 1993 Aug; 10(8):1191-9. PubMed ID: 8415407
[TBL] [Abstract][Full Text] [Related]
39. Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity, and gastrointestinal toxicity.
Shanbhag VR; Crider AM; Gokhale R; Harpalani A; Dick RM
J Pharm Sci; 1992 Feb; 81(2):149-54. PubMed ID: 1545354
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim YM
J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
